In conclusion, we demonstrated that WT161 inhibits the growth of osteosarcoma cells in a dose- and time-dependent manner and increases its apoptosis mainly by increasing the protein expression of pro-apoptotic protein PTEN and subsequently PI3K/Akt inactivation. Here, AKT1 is linked to osteosarcoma.